Enteric Empty Capsules Market Size, Share & Trends Analysis Report By Product (Gelatin Capsules, Vegetable Capsules), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030

Enteric Empty Capsules Market Size, Share & Trends Analysis Report By Product (Gelatin Capsules, Vegetable Capsules), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030

Enteric Empty Capsules Market Trends

The global enteric empty capsules market size was estimated at USD 2.96 billion in 2023 and is projected to grow at a CAGR of 6.54% from 2024 to 2030. The growth of the market is driven by an increasing demand for pharmaceutical products, growing adoption of enteric capsules by pharmaceutical companies, rising prevalence of gastrointestinal disorders, and technological advancements in capsule manufacturing.

The pharmaceutical industry’s growth is a significant driver of the enteric empty capsules market. With the increasing global population and rising healthcare awareness, there is a growing demand for pharmaceutical products worldwide. They are widely used for encapsulating various drugs, especially those sensitive to gastric acid.In May 2021, Evonik launched EUDRACAP, a commercial-scale functional capsule for fast and effective drug development. EUDRACAP, based on oral drug delivery technology, accommodates sensitive molecules, including biologicals, from early development to commercial scaling.

Pharmaceutical companies are increasingly opting for enteric capsules due to their ability to protect drugs from degradation in the acidic environment of the stomach. This trend is driving the demand for enteric empty capsules in the market.In a March 2024 study from Nutrients, researchers found that an enteric-coated tablet formulation enables sodium bicarbonate protection in acidic conditions and its release in the intestine. This approach reduces the required dose to reach a blood bicarbonate level over 5 mmol∙L−1 from 300 mg∙kg−1 to 225 mg∙kg−1, cutting the dose by 25% and lessening gastrointestinal discomfort.

The increasing prevalence of gastrointestinal disorders such as acid reflux, ulcers, and inflammatory bowel diseases is fueling the demand for enteric empty capsules. Patients with these conditions often require medications that can bypass the stomach and release their contents in the intestines. This has led to a higher utilization in drug delivery systems.In a May 2024 publication in Molecular Pharmaceutics, researchers presented enteric-coated capsules designed for precise drug delivery to the distal ileum, effectively targeting the area richest in Peyer’s patches.

Advancements in capsule manufacturing technologies contribute to the market growth. Innovations such as improved coating techniques and materials have enhanced the performance and functionality, making them more appealing to pharmaceutical manufacturers. These technological advancements increase the efficiency and reliability in drug delivery applications.In May 2021, Qualicaps Europe introduced a new range of titanium dioxide-free capsules, catering to health-conscious consumers with over 25 color options, including an innovative extra-white vegan option. With more than 120 years of expertise, the company ensures high-quality encapsulation solutions for ingredient masking, enhancing consumer healthcare products.

Global Enteric Empty Capsules Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global enteric empty capsules market report based on product, application, end-use, and region:

• Product Outlook (Revenue, USD Million, 2018 - 2030)
• Gelatin Capsules
• Hydroxypropyl Methylcellulose (HPMC) Capsules
• Vegetable Capsules
• Application Outlook (Revenue, USD Million, 2018 - 2030)
• Antacid and Antiflatulent Preparations
• Antibiotic and Antibacterial Drugs
• Others
• End-use Outlook (Revenue, USD Million, 2018 - 2030)
• Pharmaceutical Manufacturers
• Nutraceutical Manufacturers
• Others
• Regional Outlook (Revenue, USD Million, 2018 - 2030)
• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• UK
• France
• Italy
• Spain
• Denmark
• Sweden
• Norway
• Asia Pacific
• China
• Japan
• India
• South Korea
• Australia
• Thailand
• Latin America
• Brazil
• Argentina
• MEA
• South Africa
• Saudi Arabia
• UAE
• Kuwait

Please note The report will be delivered in 2-3 business days upon order notification.